添加一点使用说明吧
添加一点使用说明吧。距离屏幕多远练，一个训练几分钟会跳转到下一个么？左上角的条是设置什么的？ 一开始怕是骗人的软件，但觉得简介里那几个训练设计得好的话还蛮方便的，而且看到最近仍在更新，买了试试的。没想到训练项目还满丰富的，比简介里还多，估计有十来个，28元买断的话还蛮良心的，希望后面用起来没有别的收费了。但是说明太少了。以及如何安排每日训练还得再研究研究。
Description
歡迎來到眼睛的健康世界！
我們的「眼睛訓練工具」是一款簡單易用的眼部訓練app。
主要功能和優勢：
鍛鍊眼球追蹤、轉動、聚焦等能力，適合長時間使用電子設備的人，有助於緩解眼睛疲勞，避免眼睛疲勞影響工作效率。
眼球肌肉的專業訓練，適合學習壓力較大的人，有助於改善視力，避免視力影響提升學業成績。
視力發展的保護，適合青少年，有助於預防近視，守護視力健康。
老年人用來視力護理，有助於維持眼睛健康，並改善生活品質。
解決您的煩惱和問題：
眼睛疲勞：眼球追蹤、轉動、聚焦動畫，緩解眼睛疲勞，讓您的視野重新清晰。
視力下降：體驗Gabor圖形動畫，刺激視覺神經，提升視力，重拾敏銳度。
近視防護：遠近聚焦動畫，強化眼部肌肉調節，預防近視，讓視力更長遠。
弱視斜視：翻轉拍動畫，紅綠動畫接受更多光刺激，促進視覺發展。
下載“眼睛訓練工具”，擁有明亮健康的眼睛，享受數位世界的每一刻！
本應用程式不能取代專業醫療，有眼睛疾病者,使用前請諮詢醫生意見.如有不適,請及時就醫.
Hide
Show More...
我們的「眼睛訓練工具」是一款簡單易用的眼部訓練app。
主要功能和優勢：
鍛鍊眼球追蹤、轉動、聚焦等能力，適合長時間使用電子設備的人，有助於緩解眼睛疲勞，避免眼睛疲勞影響工作效率。
眼球肌肉的專業訓練，適合學習壓力較大的人，有助於改善視力，避免視力影響提升學業成績。
視力發展的保護，適合青少年，有助於預防近視，守護視力健康。
老年人用來視力護理，有助於維持眼睛健康，並改善生活品質。
解決您的煩惱和問題：
眼睛疲勞：眼球追蹤、轉動、聚焦動畫，緩解眼睛疲勞，讓您的視野重新清晰。
視力下降：體驗Gabor圖形動畫，刺激視覺神經，提升視力，重拾敏銳度。
近視防護：遠近聚焦動畫，強化眼部肌肉調節，預防近視，讓視力更長遠。
弱視斜視：翻轉拍動畫，紅綠動畫接受更多光刺激，促進視覺發展。
下載“眼睛訓練工具”，擁有明亮健康的眼睛，享受數位世界的每一刻！
本應用程式不能取代專業醫療，有眼睛疾病者,使用前請諮詢醫生意見.如有不適,請及時就醫.
Screenshots
眼睛訓練工具 FAQ
-
Is 眼睛訓練工具 free?
Yes, 眼睛訓練工具 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 眼睛訓練工具 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 眼睛訓練工具 cost?
眼睛訓練工具 is free.
-
What is 眼睛訓練工具 revenue?
To get estimated revenue of 眼睛訓練工具 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Hong Kong SAR China yet.
Ratings History
眼睛訓練工具 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Paid
|
|
37
|
|
Top Paid
|
|
157
|
|
Top Paid
|
|
216
|
|
Top Paid
|
|
240
|
|
Top Paid
|
|
247
|
眼睛训练工具 Installs
Last 30 days
眼睛训练工具 Revenue
Last 30 days眼睛訓練工具 Revenue and Downloads
Gain valuable insights into 眼睛训练工具 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Shanghai Liaoxiang Technology Co
- Languages
- English, Akan, Albanian, Amharic, Arabic, Armenian, Assamese, Aymara, Azerbaijani, Bambara, Basque, Belarusian, Bengali, Bosnian, Bulgarian, Burmese, Central Khmer, Catalan, Chichewa, Corsican, Croatian, Czech, Danish, Divehi, Dutch, Esperanto, Estonian, Ewe, Finnish, French, Western Frisian, Gaelic, Galician, Ganda, Georgian, German, Greek (modern), Guaraní, Gujarati, Haitian, Hausa, Hebrew (modern), Hindi, Hungarian, Icelandic, Igbo, Indonesian, Irish, Italian, Japanese, Javanese, Kannada, Kazakh, Kinyarwanda, Korean, Kurdish, Kirghiz, Lao, Latin, Latvian, Lingala, Lithuanian, Luxembourgish, Macedonian, Malagasy, Malay, Malayalam, Maltese, Maori, Marathi, Mongolian, Nepali, Norwegian Bokmål, Oriya, Oromo, Pashto, Persian, Polish, Portuguese, Panjabi, Quechua, Romanian, Russian, Samoan, Sanskrit, Serbian, Southern Sotho, Shona, Chinese, Sindhi, Sinhala, Slovak, Slovene, Somali, Spanish, Sundanese, Swahili, Swedish, Tajik, Tamil, Tatar, Telugu, Thai, Tigrinya, Tsonga, Turkish, Turkmen, Uighur, Ukrainian, Urdu, Uzbek, Vietnamese, Welsh, Xhosa, Yiddish, Yoruba, Zulu
- Recent release
- 4.3.0 (2 months ago )
- Released on
- Oct 6, 2022 (2 years ago )
- Also available in
- China, Türkiye, Italy, France, United Kingdom, Greece, Hong Kong SAR China, Croatia, Hungary, Indonesia, Ireland, Israel, India, Spain, Japan, South Korea, Malaysia, Peru, Romania, Taiwan, Ukraine, United States, Vietnam, Chile, Argentina, Austria, Australia, Azerbaijan, Belgium, Bulgaria, Brazil, Belarus, Canada, Switzerland, Finland, Colombia, Czechia, Germany, Denmark, Dominican Republic, Algeria, Ecuador, Estonia, Egypt, United Arab Emirates
- Last Updated
- 6 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.